Home > Products > CD133 & EGFR
> Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Minibody)
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Minibody) (CAT#: MiniB-031)
Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD133 scFv fused to N-terminus of Knob-CH3 domain and the anti-EGFR scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can target brain tumor stem cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (Minibody) (MiniB-031). Click the button below to contact us or submit your feedback about this product.